Korean J Med.
2025 Feb;100(1):5-18. 10.3904/kjm.2025.100.1.5.
2024 KSoLA Consensus on the Management of Secondary Dyslipidemia
- Affiliations
-
- 1Cardiovascular-Arrhythmia Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
- 3Department of Medical Nutrition, Kyung Hee University Graduate School of East-West Medical Science, Yongin, Korea
- 4Research Institute of Medical Nutrition, Kyung Hee University, Seoul, Korea
- 5Department of Food and Nutrition, Hannam University College of Life Science and Nano Technology, Daejeon, Korea
- 6Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2564340
- DOI: http://doi.org/10.3904/kjm.2025.100.1.5
Abstract
- Secondary dyslipidemia, characterized by elevated blood cholesterol and triglycerides, arises from various underlying conditions. The identification and appropriate handling of these causes is crucial for effective treatment. Major contributors include unhealthy diets, diseases impacting lipid metabolism, and medication side effects. Prioritizing the correction of secondary causes before initiating conventional lipid-lowering therapies is essential. Subsequent lipid profiles guide the selection of appropriate guideline-based lipid-lowering interventions.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- 2024 KSoLA Consensus on Secondary Dyslipidemia
- 2024 KSoLA consensus on secondary dyslipidemia
- The Comparison of Guidelines for Management of Dyslipidemia and the Appropriateness of Them in Korea
- Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction
- Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data
